← Browse by Condition
Medical Condition
esophageal diseases
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT04312633
Recruiting
Clinical Utility of WATS3D: A 5-Year Prospective Study
Enrollment
90,000 pts
Location
United States
Sponsor
CDx Diagnostics
NCT05252078 Phase 2
Recruiting
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
Enrollment
30 pts
Location
China
Sponsor
Jiangxi Provincial Cancer Hosp...